ホームページ Others Antibody-Drug Conjugate

Antibody-Drug Conjugate

Antibody-Drug Conjugate製品

  • All (3)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
E2841 Sacituzumab-govitecan Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38, showing anticancer activity.Can be dissolved and diluted with PBS. This product is supplied as 10mg/ml PBS solution.
Sci Rep, 2025, 15(1):409
Exp Dermatol, 2024, 33(10):e15196
E0200 Trastuzumab-deruxtecan (DS-8201a, T-DXd) Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. This product is supplied as 10mg/ml PBS solution.
JCI Insight, 2025, 10(16)e187151
E2851 Trastuzumab-Emtansine（T-DM1） Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.This product is supplied as 10mg/ml PBS solution.
united states